O	O	O	0	5	Human	Human	B-NP	JJ	O	2	NMOD	O
O	O	O	6	21	cytomegalovirus	cytomegalovirus	I-NP	NN	O	7	SUB	O
O	O	O	22	29	binding	bind	B-VP	VBG	O	2	NMOD	O
O	O	O	30	32	to	to	B-PP	TO	O	2	NMOD	O
O	O	O	33	38	human	human	B-NP	JJ	B-cell_type	6	NMOD	B-cell_type
O	O	O	39	48	monocytes	monocyte	I-NP	NNS	I-cell_type	4	PMOD	I-cell_type
O	O	O	49	56	induces	induce	B-VP	VBZ	O	0	ROOT	O
T9	B-Entity	B-Entity	57	73	immunoregulatory	immunoregulatory	B-NP	JJ	O	10	NMOD	O
T9	I-Entity	I-Entity	74	78	gene	gene	I-NP	NN	O	10	NMOD	O
O	O	O	79	89	expression	expression	I-NP	NN	O	7	OBJ	O
O	O	O	89	90	.	.	O	.	O	7	P	O

O	O	O	92	94	To	To	B-VP	TO	O	2	VMOD	O
O	O	O	95	103	continue	continue	I-VP	VB	O	20	VMOD	O
O	O	O	104	107	our	our	B-NP	PRP$	O	4	NMOD	O
O	O	O	108	121	investigation	investigation	I-NP	NN	O	2	OBJ	O
O	O	O	122	124	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	125	128	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	129	137	cellular	cellular	I-NP	JJ	O	8	NMOD	O
O	O	O	138	144	events	event	I-NP	NNS	O	5	PMOD	O
O	O	O	145	149	that	that	B-NP	WDT	O	8	NMOD	O
O	O	O	150	155	occur	occur	B-VP	VBP	O	9	SBAR	O
O	O	O	156	165	following	follow	I-VP	VBG	O	10	VMOD	O
O	O	O	166	171	human	human	B-NP	JJ	O	13	NMOD	O
O	O	O	172	175	CMV	CMV	I-NP	NN	O	17	NMOD	O
O	O	O	176	177	(	(	O	(	O	16	DEP	O
O	O	O	177	181	HCMV	HCMV	B-NP	NN	O	16	DEP	O
O	O	O	181	182	)	)	O	)	O	13	NMOD	O
O	O	O	183	192	infection	infection	B-NP	NN	O	11	PMOD	O
O	O	O	192	193	,	,	O	,	O	20	P	O
O	O	O	194	196	we	we	B-NP	PRP	O	20	SUB	O
O	O	O	197	204	focused	focus	B-VP	VBD	O	0	ROOT	O
O	O	O	205	207	on	on	B-PP	IN	O	20	VMOD	O
O	O	O	208	211	the	the	B-NP	DT	O	23	NMOD	O
O	O	O	212	222	regulation	regulation	I-NP	NN	O	21	PMOD	O
O	O	O	223	225	of	of	B-PP	IN	O	23	NMOD	O
O	O	O	226	234	cellular	cellular	B-NP	JJ	O	26	NMOD	O
O	O	O	235	245	activation	activation	I-NP	NN	O	24	PMOD	O
O	O	O	246	255	following	follow	B-PP	VBG	O	26	NMOD	O
O	O	O	256	261	viral	viral	B-NP	JJ	O	29	NMOD	O
O	O	O	262	269	binding	binding	I-NP	NN	O	27	PMOD	O
O	O	O	270	272	to	to	B-PP	TO	O	29	NMOD	O
O	O	O	273	278	human	human	B-NP	JJ	B-cell_type	32	NMOD	B-cell_type
O	O	O	279	288	monocytes	monocyte	I-NP	NNS	I-cell_type	30	PMOD	I-cell_type
O	O	O	288	289	.	.	O	.	O	20	P	O

O	O	O	290	295	First	First	B-ADVP	RB	O	4	VMOD	O
O	O	O	295	296	,	,	O	,	O	4	P	O
O	O	O	297	299	we	we	B-NP	PRP	O	4	SUB	O
O	O	O	300	306	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	O	307	311	that	that	B-SBAR	IN	O	36	DEP	O
O	O	O	312	317	viral	viral	B-NP	JJ	O	7	NMOD	O
O	O	O	318	325	binding	binding	I-NP	NN	O	8	SUB	O
O	O	O	326	333	induced	induce	B-VP	VBD	O	5	SBAR	O
O	O	O	334	335	a	a	B-NP	DT	O	10	NMOD	O
O	O	O	336	342	number	number	I-NP	NN	O	8	OBJ	O
O	O	O	343	345	of	of	B-PP	IN	O	10	NMOD	O
T10	B-Entity	B-Entity	346	362	immunoregulatory	immunoregulatory	B-NP	JJ	B-DNA	13	NMOD	B-DNA
T10	I-Entity	I-Entity	363	368	genes	gene	I-NP	NNS	I-DNA	11	PMOD	I-DNA
O	O	O	369	370	(	(	O	(	O	31	DEP	O
T1	B-Protein	B-Protein	370	372	IL	IL	B-NP	NN	B-protein	23	NMOD	B-protein
T1	I-Protein	I-Protein	372	373	-	-	O	HYPH	I-protein	23	P	I-protein
T1	I-Protein	I-Protein	373	378	1beta	1beta	B-NP	NN	I-protein	23	NMOD	I-protein
O	O	O	378	379	,	,	O	,	O	23	P	O
T2	B-Protein	B-Protein	380	383	A20	A20	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	O	383	384	,	,	O	,	O	23	P	O
T11	B-Entity	B-Entity	385	387	NF	NF	B-NP	NN	B-protein	23	NMOD	B-protein
T11	I-Entity	I-Entity	387	388	-	-	B-NP	HYPH	I-protein	23	NMOD	I-protein
T11	I-Entity	I-Entity	388	394	kappaB	kappaB	I-NP	NN	I-protein	27	NMOD	I-protein
T11	I-Entity	I-Entity	394	395	-	-	B-NP	HYPH	O	27	NMOD	O
T3,T11	B-Protein,I-Entity	B-Protein,I-Entity	395	399	p105	p105	I-NP	NN	B-protein	27	NMOD	B-protein
T11	I-Entity	I-Entity	399	400	/	/	B-NP	SYM	O	27	NMOD	O
T4,T11	B-Protein,I-Entity	B-Protein,I-Entity	400	403	p50	p50	I-NP	NN	B-protein	30	NMOD	B-protein
O	O	O	403	404	,	,	O	,	O	30	P	O
O	O	O	405	408	and	and	O	CC	O	30	NMOD	O
T5	B-Protein	B-Protein	409	421	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	31	DEP	B-protein
O	O	O	421	422	)	)	O	)	O	13	NMOD	O
O	O	O	423	425	in	in	B-PP	IN	O	8	VMOD	O
O	O	O	426	437	unactivated	unactivated	B-NP	JJ	O	34	NMOD	O
O	O	O	438	447	monocytes	monocyte	I-NP	NNS	B-cell_type	32	PMOD	B-cell_type
O	O	O	448	451	and	and	O	CC	O	36	DEP	O
O	O	O	452	456	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	O	457	469	neutralizing	neutralize	B-VP	VBG	B-protein	38	NMOD	B-protein
O	O	O	470	473	Abs	Ab	B-NP	NNS	I-protein	55	SUB	I-protein
O	O	O	474	476	to	to	B-PP	TO	O	38	NMOD	O
O	O	O	477	480	the	the	B-NP	DT	O	43	NMOD	O
O	O	O	481	486	major	major	I-NP	JJ	O	43	NMOD	O
O	O	O	487	491	HCMV	HCMV	I-NP	NN	B-protein	43	NMOD	B-protein
O	O	O	492	505	glycoproteins	glycoprotein	I-NP	NNS	I-protein	50	NMOD	I-protein
O	O	O	505	506	,	,	O	,	O	50	P	O
O	O	O	507	509	gB	gB	B-NP	NN	B-protein	50	NMOD	B-protein
O	O	O	510	511	(	(	O	(	O	48	DEP	O
O	O	O	511	515	UL55	UL55	B-NP	NN	B-protein	48	DEP	B-protein
O	O	O	515	516	)	)	O	)	O	45	NMOD	O
O	O	O	517	520	and	and	O	CC	O	50	NMOD	O
O	O	O	521	523	gH	gH	B-NP	NN	B-protein	39	PMOD	B-protein
O	O	O	524	525	(	(	O	(	O	53	DEP	O
O	O	O	525	529	UL75	UL75	B-NP	NN	B-protein	53	DEP	B-protein
O	O	O	529	530	)	)	O	)	O	50	NMOD	O
O	O	O	530	531	,	,	O	,	O	50	P	O
O	O	O	532	541	inhibited	inhibit	B-VP	VBD	O	36	SBAR	O
O	O	O	542	545	the	the	B-NP	DT	O	57	NMOD	O
O	O	O	546	555	induction	induction	I-NP	NN	O	55	OBJ	O
O	O	O	556	558	of	of	B-PP	IN	O	57	NMOD	O
O	O	O	559	564	these	these	B-NP	DT	O	60	NMOD	O
O	O	O	565	570	genes	gene	I-NP	NNS	O	58	PMOD	O
O	O	O	570	571	.	.	O	.	O	4	P	O

O	O	O	572	576	Next	Next	B-ADVP	RB	O	4	VMOD	O
O	O	O	576	577	,	,	O	,	O	4	P	O
O	O	O	578	580	we	we	B-NP	PRP	O	4	SUB	O
O	O	O	581	593	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	O	594	598	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	O	599	604	these	these	B-NP	DT	O	8	NMOD	O
O	O	O	605	610	viral	viral	I-NP	JJ	O	8	NMOD	O
O	O	O	611	618	ligands	ligand	I-NP	NNS	O	12	SUB	O
O	O	O	619	627	directly	directly	B-ADVP	RB	O	12	VMOD	O
O	O	O	628	630	up	up	B-ADVP	RB	O	9	AMOD	O
O	O	O	630	631	-	-	I-ADVP	HYPH	O	9	AMOD	O
O	O	O	631	640	regulated	regulate	B-NP	VBN	O	15	NMOD	O
O	O	O	641	649	monocyte	monocyte	I-NP	NN	O	15	NMOD	O
O	O	O	650	654	gene	gene	I-NP	NN	O	15	NMOD	O
O	O	O	655	665	expression	expression	I-NP	NN	O	5	SBAR	O
O	O	O	666	670	upon	upon	B-PP	IN	O	15	NMOD	O
O	O	O	671	676	their	their	B-NP	PRP$	O	18	NMOD	O
O	O	O	677	684	binding	binding	I-NP	NN	O	16	PMOD	O
O	O	O	685	687	to	to	B-PP	TO	O	18	NMOD	O
O	O	O	688	693	their	their	B-NP	PRP$	O	23	NMOD	O
O	O	O	694	705	appropriate	appropriate	I-NP	JJ	O	23	NMOD	O
O	O	O	706	714	cellular	cellular	I-NP	JJ	O	23	NMOD	O
O	O	O	715	724	receptors	receptor	I-NP	NNS	O	19	PMOD	O
O	O	O	724	725	.	.	O	.	O	4	P	O

O	O	O	726	728	We	We	B-NP	PRP	O	3	SUB	O
O	O	O	729	733	then	then	B-ADVP	RB	O	3	VMOD	O
O	O	O	734	746	investigated	investigate	B-VP	VBD	O	0	ROOT	O
O	O	O	747	749	if	if	B-SBAR	IN	O	3	VMOD	O
O	O	O	750	754	HCMV	HCMV	B-NP	NN	O	6	NMOD	O
O	O	O	755	762	binding	binding	I-NP	NN	O	8	SUB	O
O	O	O	763	767	also	also	B-ADVP	RB	O	8	VMOD	O
O	O	O	768	776	resulted	result	B-VP	VBD	O	4	SBAR	O
O	O	O	777	779	in	in	B-PP	IN	O	8	VMOD	O
O	O	O	780	783	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	784	795	translation	translation	I-NP	NN	O	13	NMOD	O
O	O	O	796	799	and	and	I-NP	CC	O	13	NMOD	O
O	O	O	800	809	secretion	secretion	I-NP	NN	O	9	PMOD	O
O	O	O	810	812	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	813	822	cytokines	cytokine	B-NP	NNS	B-protein	14	PMOD	B-protein
O	O	O	822	823	.	.	O	.	O	3	P	O

O	O	O	824	827	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	O	828	835	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	836	842	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	O	843	847	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	848	852	HCMV	HCMV	B-NP	NN	O	6	NMOD	O
O	O	O	853	860	binding	binding	I-NP	NN	O	9	SUB	O
O	O	O	861	863	to	to	B-PP	TO	O	6	NMOD	O
O	O	O	864	873	monocytes	monocyte	B-NP	NNS	B-cell_type	7	PMOD	B-cell_type
O	O	O	874	882	resulted	result	B-VP	VBD	O	4	SBAR	O
O	O	O	883	885	in	in	B-PP	IN	O	9	VMOD	O
O	O	O	886	889	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	890	900	production	production	I-NP	NN	O	14	NMOD	O
O	O	O	901	904	and	and	I-NP	CC	O	14	NMOD	O
O	O	O	905	912	release	release	I-NP	NN	O	10	PMOD	O
O	O	O	913	915	of	of	B-PP	IN	O	14	NMOD	O
T6	B-Protein	B-Protein	916	918	IL	IL	B-NP	NN	B-protein	19	NMOD	B-protein
T6	I-Protein	I-Protein	918	919	-	-	B-NP	HYPH	I-protein	19	NMOD	I-protein
T6	I-Protein	I-Protein	919	924	1beta	1beta	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	O	925	932	protein	protein	I-NP	NN	I-protein	15	PMOD	I-protein
O	O	O	932	933	.	.	O	.	O	3	P	O

O	O	O	934	941	Because	Because	B-SBAR	IN	O	18	VMOD	O
O	O	O	942	947	these	these	B-NP	DT	O	5	NMOD	O
O	O	O	948	955	induced	induce	I-NP	VBN	O	5	NMOD	O
O	O	O	956	960	gene	gene	I-NP	NN	O	5	NMOD	O
O	O	O	961	969	products	product	I-NP	NNS	O	6	SUB	O
O	O	O	970	974	have	have	B-VP	VBP	O	1	SBAR	O
T12,T13	B-Entity,B-Entity	B-Entity,B-Entity	975	977	NF	NF	B-NP	NN	B-protein	9	NMOD	B-protein
T12,T13	I-Entity,I-Entity	I-Entity,I-Entity	977	978	-	-	B-NP	HYPH	O	9	P	O
T12,T13	I-Entity,I-Entity	I-Entity,I-Entity	978	984	kappaB	kappaB	I-NP	NN	B-DNA	10	NMOD	B-DNA
T12	I-Entity	I-Entity	985	990	sites	site	I-NP	NNS	I-DNA	6	OBJ	I-DNA
O	O	O	991	993	in	in	B-PP	IN	O	6	VMOD	O
O	O	O	994	999	their	their	B-NP	PRP$	O	14	NMOD	O
T14	B-Entity	B-Entity	1000	1008	promoter	promoter	I-NP	NN	B-DNA	14	NMOD	B-DNA
T14	I-Entity	I-Entity	1009	1016	regions	region	I-NP	NNS	I-DNA	11	PMOD	I-DNA
O	O	O	1016	1017	,	,	O	,	O	18	P	O
O	O	O	1018	1020	we	we	B-NP	PRP	O	18	SUB	O
O	O	O	1021	1025	next	next	B-ADVP	RB	O	18	VMOD	O
O	O	O	1026	1034	examined	examine	B-VP	VBD	O	0	ROOT	O
O	O	O	1035	1042	whether	whether	B-SBAR	IN	O	18	VMOD	O
O	O	O	1043	1048	there	there	B-NP	EX	O	21	SUB	O
O	O	O	1049	1052	was	be	B-VP	VBD	O	19	SBAR	O
O	O	O	1053	1055	an	an	B-NP	DT	O	25	NMOD	O
O	O	O	1056	1058	up	up	I-NP	RB	O	24	AMOD	O
O	O	O	1058	1059	-	-	I-NP	HYPH	O	25	NMOD	O
O	O	O	1059	1069	regulation	regulation	B-NP	NN	O	21	PRD	O
O	O	O	1070	1072	of	of	B-PP	IN	O	25	NMOD	O
O	O	O	1073	1080	nuclear	nuclear	B-NP	JJ	B-protein	31	NMOD	B-protein
T15	B-Entity	B-Entity	1081	1083	NF	NF	I-NP	NN	I-protein	31	NMOD	I-protein
T15	I-Entity	I-Entity	1083	1084	-	-	B-NP	HYPH	I-protein	31	NMOD	I-protein
T15	I-Entity	I-Entity	1084	1090	kappaB	kappaB	I-NP	NN	I-protein	31	NMOD	I-protein
O	O	O	1091	1097	levels	level	I-NP	NNS	O	26	PMOD	O
O	O	O	1097	1098	.	.	O	.	O	18	P	O

O	O	O	1099	1104	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1105	1116	experiments	experiment	I-NP	NNS	O	3	SUB	O
O	O	O	1117	1123	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	O	1124	1128	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1128	1129	,	,	O	,	O	4	P	O
O	O	O	1130	1132	in	in	B-PP	IN	O	12	VMOD	O
O	O	O	1133	1137	fact	fact	B-NP	NN	O	6	PMOD	O
O	O	O	1137	1138	,	,	O	,	O	12	P	O
T16	B-Entity	B-Entity	1139	1141	NF	NF	B-NP	NN	B-protein	11	NMOD	B-protein
T16	I-Entity	I-Entity	1141	1142	-	-	B-NP	HYPH	I-protein	11	NMOD	I-protein
T16	I-Entity	I-Entity	1142	1148	kappaB	kappaB	I-NP	NN	I-protein	12	SUB	I-protein
O	O	O	1149	1152	was	be	B-VP	VBD	O	4	SBAR	O
O	O	O	1153	1165	translocated	translocate	I-VP	VBN	O	12	VC	O
O	O	O	1166	1168	to	to	B-PP	TO	O	13	VMOD	O
O	O	O	1169	1172	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	1173	1180	nucleus	nucleus	I-NP	NN	O	14	PMOD	O
O	O	O	1181	1190	following	follow	B-PP	VBG	O	13	VMOD	O
O	O	O	1191	1196	viral	viral	B-NP	JJ	O	19	NMOD	O
O	O	O	1197	1204	binding	binding	I-NP	NN	O	24	NMOD	O
O	O	O	1205	1207	or	or	O	CC	O	24	NMOD	O
O	O	O	1208	1216	purified	purify	B-VP	VBN	O	24	NMOD	O
O	O	O	1217	1222	viral	viral	B-NP	JJ	O	24	NMOD	O
O	O	O	1223	1229	ligand	ligand	I-NP	NN	O	24	NMOD	O
O	O	O	1230	1237	binding	binding	I-NP	NN	O	17	PMOD	O
O	O	O	1237	1238	.	.	O	.	O	3	P	O

O	O	O	1239	1246	Changes	Change	B-NP	NNS	O	5	SUB	O
O	O	O	1247	1249	in	in	B-PP	IN	O	1	NMOD	O
T7	B-Protein	B-Protein	1250	1262	IkappaBalpha	IkappaBalpha	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	O	1263	1269	levels	level	I-NP	NNS	O	2	PMOD	O
O	O	O	1270	1280	correlated	correlate	B-VP	VBD	O	0	ROOT	O
O	O	O	1281	1285	with	with	B-PP	IN	O	5	VMOD	O
O	O	O	1286	1289	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	1290	1297	changes	change	I-NP	NNS	O	6	PMOD	O
O	O	O	1298	1300	in	in	B-PP	IN	O	8	NMOD	O
T17	B-Entity	B-Entity	1301	1303	NF	NF	B-NP	NN	B-protein	13	NMOD	B-protein
T17	I-Entity	I-Entity	1303	1304	-	-	B-NP	HYPH	I-protein	13	NMOD	I-protein
T17	I-Entity	I-Entity	1304	1310	kappaB	kappaB	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	O	1311	1324	translocation	translocation	I-NP	NN	O	9	PMOD	O
O	O	O	1324	1325	.	.	O	.	O	5	P	O

O	O	O	1326	1332	Lastly	Lastly	B-ADVP	RB	O	4	VMOD	O
O	O	O	1332	1333	,	,	O	,	O	4	P	O
O	O	O	1334	1336	we	we	B-NP	PRP	O	4	SUB	O
O	O	O	1337	1349	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	O	1350	1354	that	that	B-SBAR	IN	O	19	DEP	O
O	O	O	1355	1358	p38	p38	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	1359	1365	kinase	kinase	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	O	1366	1374	activity	activity	I-NP	NN	O	9	SUB	O
O	O	O	1375	1381	played	play	B-VP	VBD	O	5	SBAR	O
O	O	O	1382	1383	a	a	B-NP	DT	O	12	NMOD	O
O	O	O	1384	1391	central	central	I-NP	JJ	O	12	NMOD	O
O	O	O	1392	1396	role	role	I-NP	NN	O	9	OBJ	O
O	O	O	1397	1399	in	in	B-PP	IN	O	9	VMOD	O
T8	B-Protein	B-Protein	1400	1402	IL	IL	B-NP	NN	B-protein	17	NMOD	B-protein
T8	I-Protein	I-Protein	1402	1403	-	-	B-NP	HYPH	I-protein	17	NMOD	I-protein
T8	I-Protein	I-Protein	1403	1408	1beta	1beta	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	O	1409	1419	production	production	I-NP	NN	O	13	PMOD	O
O	O	O	1420	1423	and	and	O	CC	O	19	DEP	O
O	O	O	1424	1428	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	O	1429	1431	it	it	B-NP	PRP	O	21	SUB	O
O	O	O	1432	1435	was	be	B-VP	VBD	O	19	SBAR	O
O	O	O	1436	1443	rapidly	rapidly	B-ADVP	RB	O	21	VMOD	O
O	O	O	1444	1446	up	up	B-ADVP	RB	O	25	VMOD	O
O	O	O	1446	1447	-	-	O	HYPH	O	23	AMOD	O
O	O	O	1447	1456	regulated	regulate	B-VP	VBN	O	21	VMOD	O
O	O	O	1457	1466	following	follow	B-PP	VBG	O	25	VMOD	O
O	O	O	1467	1476	infection	infection	B-NP	NN	O	26	PMOD	O
O	O	O	1476	1477	.	.	O	.	O	4	P	O

O	O	O	1478	1483	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1484	1491	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1492	1499	support	support	B-VP	VBP	O	0	ROOT	O
O	O	O	1500	1503	our	our	B-NP	PRP$	O	5	NMOD	O
O	O	O	1504	1514	hypothesis	hypothesis	I-NP	NN	O	3	OBJ	O
O	O	O	1515	1519	that	that	B-SBAR	IN	O	5	NMOD	O
O	O	O	1520	1524	HCMV	HCMV	B-NP	NN	O	8	SUB	O
O	O	O	1525	1534	initiates	initiate	B-VP	VBZ	O	6	SBAR	O
O	O	O	1535	1536	a	a	B-NP	DT	O	12	NMOD	O
O	O	O	1537	1543	signal	signal	I-NP	NN	O	12	NMOD	O
O	O	O	1544	1556	transduction	transduction	I-NP	NN	O	12	NMOD	O
O	O	O	1557	1564	pathway	pathway	I-NP	NN	O	8	OBJ	O
O	O	O	1565	1569	that	that	B-NP	WDT	O	12	NMOD	O
O	O	O	1570	1575	leads	lead	B-VP	VBZ	O	13	SBAR	O
O	O	O	1576	1578	to	to	B-PP	TO	O	14	VMOD	O
O	O	O	1579	1587	monocyte	monocyte	B-NP	NN	O	17	NMOD	O
O	O	O	1588	1598	activation	activation	I-NP	NN	O	15	PMOD	O
O	O	O	1599	1602	and	and	O	CC	O	14	VMOD	O
O	O	O	1603	1612	pinpoints	pinpoint	B-VP	VBZ	O	14	VMOD	O
O	O	O	1613	1614	a	a	B-NP	DT	O	22	NMOD	O
O	O	O	1615	1624	potential	potential	I-NP	JJ	O	22	NMOD	O
O	O	O	1625	1634	mechanism	mechanism	I-NP	NN	O	19	OBJ	O
O	O	O	1635	1642	whereby	whereby	B-ADVP	WRB	O	22	NMOD	O
O	O	O	1643	1647	HCMV	HCMV	B-NP	NN	O	25	NMOD	O
O	O	O	1648	1657	infection	infection	I-NP	NN	O	28	SUB	O
O	O	O	1658	1660	of	of	B-PP	IN	O	25	NMOD	O
O	O	O	1661	1670	monocytes	monocyte	B-NP	NNS	B-cell_type	26	PMOD	B-cell_type
O	O	O	1671	1674	can	can	B-VP	MD	O	23	SBAR	O
O	O	O	1675	1681	result	result	I-VP	VB	O	28	VC	O
O	O	O	1682	1684	in	in	B-PP	IN	O	29	VMOD	O
O	O	O	1685	1693	profound	profound	B-NP	JJ	O	32	NMOD	O
O	O	O	1694	1706	pathogenesis	pathogenesis	I-NP	NN	O	30	PMOD	O
O	O	O	1706	1707	,	,	O	,	O	29	P	O
O	O	O	1708	1718	especially	especially	B-ADVP	RB	O	35	PMOD	O
O	O	O	1719	1721	in	in	B-PP	IN	O	29	VMOD	O
O	O	O	1722	1729	chronic	chronic	B-NP	JJ	O	40	NMOD	O
O	O	O	1730	1742	inflammatory	inflammatory	I-NP	JJ	O	40	NMOD	O
O	O	O	1742	1743	-	-	I-NP	HYPH	O	40	NMOD	O
O	O	O	1743	1747	type	type	I-NP	NN	O	40	NMOD	O
O	O	O	1748	1758	conditions	condition	I-NP	NNS	O	35	PMOD	O
O	O	O	1758	1759	.	.	O	.	O	3	P	O
